Biden science adviser conflicted out of COVID vaccine work




  • In Business
  • 2021-02-23 01:43:37Z
  • By Axios
 

President Biden's pick for top government scientist will have to refrain from working on COVID vaccine matters until he divests as much as $1 million of stock in a company manufacturing one, the White House tells Axios.

Why it matters: Dr. Eric Lander also won't work on any other issues that could affect his sizable portfolio until he's fully divested, the White House said. That could take months, potentially handicapping a key administration hand at a crucial time.

Get market news worthy of your time with Axios Markets. Subscribe for free.

What's new: In financial disclosure paperwork made public Monday, Lander, a renowned MIT geneticist nominated to lead the White House Office of Science and Technology Policy, disclosed owning stock worth between $500,000 and $1 million in the company BioNTech.

  • The company is manufacturing a vaccine with Pfizer that was among the first two to receive emergency use authorization.

  • It was just one of scores of holdings in Lander's portfolio, which includes numerous other pharmaceutical and biotechnology companies.

  • Lander was the founder of the biopharmaceutical company Codiak Biosciences, and disclosed equity in the company worth between $5 million and $25 million. That company has also sought to develop a COVID vaccine.

  • A major Codiak investor, venture capital firm Flagship Pioneering, is run by the founder and chairman of COVID vaccine developer Moderna.

What they're saying: A White House spokesperson told Axios that Lander, who is working with the White House even as the Senate considers his nomination, is not participating in decisions that would constitute financial conflicts.

  • "Dr. Lander is recused from particular matters related to any stocks he holds pending divestiture, including any such matters related to COVID vaccines," a White House spokesperson told Axios.

  • Lander is currently advising the Office of Science and Technology Policy, the spokesperson said, and "is complying with all applicable ethics rules and appropriate recusals are in place pending divestiture."

The bottom line: Lander plans to divest his individual stock holdings if confirmed. But until he does, he'll be barred from participating in matters that could benefit BioNTech unless he receives a waiver of relevant ethics rules.

  • That divestment could take up to 90 days, Lander told federal ethics officials, and he's joining an administration working to roll out the Pfizer-BioNTech vaccine at a breakneck pace.

COMMENTS

More Related News

White House confirms Chicago US Attorney John Lausch to stay for now
White House confirms Chicago US Attorney John Lausch to stay for now

The White House waited until the eleventh hour before publicly confirming Sunday that Chicago's top federal prosecutor will not be forced to resign as...

AstraZeneca has sold its stake in Moderna for more than $1 billion -The Times
AstraZeneca has sold its stake in Moderna for more than $1 billion -The Times

The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna. AstraZeneca and Moderna did not immediately...

Trump grasps for relevance in first post-presidential speech at CPAC
Trump grasps for relevance in first post-presidential speech at CPAC
  • World
  • 2021-03-01 00:49:08Z

Twice-impeached ex-president used speech at rightwing event to propagate the lie of a 'rigged' 2020 election and hinted at 2024 run Donald Trump at CPAC in...

Team Biden About to Start Its First Talks With the Taliban
Team Biden About to Start Its First Talks With the Taliban
  • World
  • 2021-03-01 00:14:38Z

GettyPresident Biden's Afghanistan negotiator has begun a diplomatic trip that will include the first meeting of the new administration with the Taliban...

Utah cancels thousands of vaccine appointments after glitch
Utah cancels thousands of vaccine appointments after glitch

It was a rocky moment for the COVID-19 vaccine rollout in the Mountain West. The Utah Department of Health said Sunday that it had to scratch inoculation...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business